Lloreda Camacho & Co is an esteemed intellectual property practice group with a stellar reputation in the patent space that is frequently sought after by multinational pharmaceutical and consumer goods companies to assist with complex cases related to patent registration and infringement. The firm offers additional skills in the trade mark space, including handling registrations and opposition proceedings, as well as advising on anti-counterfeiting cases. Levapan, Plexium and Xinthera are among new client wins in 2024.
Lloreda Camacho & Co is an innovative law firm that has accompanied its clients for more than 80 years in building successful legal strategies.
The firm is recognised in Colombia as a leading Intellectual Property law firm and for its experience and ability to understand the needs and projects of its clients within their businesses. Lloreda Camacho's partners are highlighted by their clients and by different international media as the best in their field, for their ability to design comprehensive strategies with high ethical and legal standards that allow them to obtain the highest protection of their Copyright and Social Media, Brands and Patents, and in this way achieving their clients' goals.
Lloreda Camacho & Co. is considered in Colombia as one of the most renowned and experienced law firms in this field. It stands out for offering guidance that seeks to differentiate through a comprehensive advice and 360-degree support. They understand the complexity of the practice and therefore identify the needs of the companies. These has led them to create an interdisciplinary group with experts from several areas including Regulatory, Patents, Competition, Compliance, Data Privacy, Contracts, among others, which allows them to become strategic partners for companies in the health sector. Lloreda Camacho represents major biotechnology, medical device, pharmaceuticals (human and veterinary), R&D, food and beverage and cosmetics, local and foreign companies in Colombia. Known for counseling their clients on a full range of regulatory, patent, contracts, data privacy and competition life science’s related issues. Also, they advise their clients on strategies for Marketing Authorisation (preparation and prosecution of applications for health registrations, renewals, modifications, certifications and authorisations with INVIMA that is the National Regulatory Agency in Colombia); Promotional Practices; and Post-Marketing Safety Plans. Their advice includes antitrust considerations, and they counsel companies on market practices that are fully compliant. Lloreda has helped their clients to structure complex agreements on shared risk, as well as innovative agreements in the sector that include relations with different partners, which are also aimed to promote access. The Life Sciences team is also specialised and well-known for its active patent practice in the biopharmaceutical sector in the Latin America Region.
Lloreda Camacho & Co advises local and foreign financial institutions, insurance companies and other entities of the financial sector, in matters related to financial and capital market operations, regulation applicable to the development of their businesses, development of new products, incorporation and acquisition of financial institutions, and in the opening of representation offices in Colombia by foreign institutions. The regulatory and industry knowledge gives them the possibility of being a leading player in the development of the Fintech industry in the country.
Data Privacy & Protection:
The team advises their clients from a local regulation point of view, as well as in conjunction with other jurisdictions. They analyse the relevance and impact that the commercial and corporate initiatives of their clients may have with regards to the current regulation in Colombia, as well as foreign regulations that may be applicable. Their aim is to help their clients with strategies and initiatives in accordance with the regulation, which may have positive impact on their businesses and be consistent with global developments.
Key Clients:
McCann Erikson, Claro, Gilat, Herbalife, MSD, Roche, Johnson & Johnson, Abbott, Anglo American, IPG Mediabrands, Goodyear, Levapan, ENEL, Alstom, Willis Towers Watson, Boehringer Ingelheim, Janssen, Eli Lilly, AstraZeneca, Gilead, Glaxo Smith Kline, Continental Gold, Sanofi.
